BridgeBio Pharma, Inc. (BBIO) — EPS (Diluted)
| Fiscal Year | EPS (Diluted) | Change YoY |
|---|---|---|
| 2025 | $-3.78 | -31.2% |
| 2024 | $-2.88 | +27.1% |
| 2023 | $-3.95 | -21.2% |
| 2022 | $-3.26 | +16.4% |
| 2021 | $-3.90 | -2.6% |
| 2020 | $-3.80 | — |
| Fiscal Year | EPS (Diluted) | Change YoY |
|---|---|---|
| 2025 | $-3.78 | -31.2% |
| 2024 | $-2.88 | +27.1% |
| 2023 | $-3.95 | -21.2% |
| 2022 | $-3.26 | +16.4% |
| 2021 | $-3.90 | -2.6% |
| 2020 | $-3.80 | — |